• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES) Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Urinary Retention (2119); Urinary Tract Infection (2120); Dysuria (2684); Unspecified Kidney or Urinary Problem (4503)
Event Date 04/01/2019
Event Type  Injury  
Event Description
It was reported to boston scientific via an article published in journal of sexual medicine that a prospective study was conducted to evaluate a prostatic block in a cohort of patients receiving a water vapor therapy procedure, in improving short term exacerbation of lower urinary tract dysfunction (luts).A total of 93 patients who underwent a water vapor therapy for benign prostatic hyperplasia (bph) in a single surgeon retrospective study was evaluated.All patients underwent a prostatic block, patient reported outcomes and complication rates were reviewed.Patients were selected to receive the therapy if prostate size was less than <110 grams, international prostate symptom score (ipps) score >15, and a desire for a minimally invasive luts treatment.Patients were given a post op course of antibiotics and instructed to take tylenol or non-steroidal anti-inflammatory drugs (nsaids) as needed.Post-procedure patients were sent home with a foley catheter for 48 hours.Patients were given a prostatic block consisting of 5 cc of 0.5% lidocaine and 5cc of 0.5% bupivicaine.The patients received transrectal ultrasound guided 2 cc injections, 2 cc by the bladder neck and sphincter, 2cc midline by the prostate and seminal vesicle junction, 2 cc by each prostatic capsule, and 2 cc by the prostatic midline septum.Mild exacerbation of luts or dysuria was reported in 9% (9/93) of patients.No patients reported luts exacerbation < 36 hours post procedure.No patients required post-op narcotics, pyridium or any anticholinergic.Two patients required replacement of foley catheter, one patient developed retention 1-week post-op and one patient developed a febrile urinary tract infection (uti).The prostatic block provided long-acting prostatic anesthesia, that reduced post-procedure discomfort.This was likely due to slow acclimation to the catheter placement while still having effective local anesthetic at the bladder neck and sphincter.
 
Manufacturer Narrative
There was no device available for analysis; therefore, no physical or visual analysis of the product could be performed.The reported patient symptoms are a known risk associated with implant of these devices as indicated in the instructions for use.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REZUM
Type of Device
UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer Contact
john stoffregen
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key17127230
MDR Text Key317206145
Report Number2124215-2023-27296
Device Sequence Number1
Product Code KNS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 06/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/22/2023
Initial Date FDA Received06/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-